Brainstorm Dividend Paid And Capex Coverage Ratio from 2010 to 2024
| BCLI Stock | USD 1.74 0.12 7.41% |
Dividend Paid And Capex Coverage Ratio | First Reported 2010-12-31 | Previous Quarter -1.1 K | Current Value -1.1 K | Quarterly Volatility 390.97071271 |
Check Brainstorm Cell financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Brainstorm Cell's main balance sheet or income statement drivers, such as Depreciation And Amortization of 304.4 K, Interest Expense of 515 K or Selling General Administrative of 11.2 M, as well as many indicators such as Dividend Yield of 0.0, Invested Capital of 0.0 or Average Payables of 380.1 K. Brainstorm financial statements analysis is a perfect complement when working with Brainstorm Cell Valuation or Volatility modules.
Brainstorm | Dividend Paid And Capex Coverage Ratio |
Latest Brainstorm Cell's Dividend Paid And Capex Coverage Ratio Growth Pattern
Below is the plot of the Dividend Paid And Capex Coverage Ratio of Brainstorm Cell Therapeutics over the last few years. It is Brainstorm Cell's Dividend Paid And Capex Coverage Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Brainstorm Cell's overall financial position and show how it may be relating to other accounts over time.
| Dividend Paid And Capex Coverage Ratio | 10 Years Trend |
|
Dividend Paid And Capex Coverage Ratio |
| Timeline |
Brainstorm Dividend Paid And Capex Coverage Ratio Regression Statistics
| Arithmetic Mean | (232.95) | |
| Coefficient Of Variation | (167.83) | |
| Mean Deviation | 291.15 | |
| Median | (46.31) | |
| Standard Deviation | 390.97 | |
| Sample Variance | 152,858 | |
| Range | 1.1K | |
| R-Value | (0.71) | |
| Mean Square Error | 82,330 | |
| R-Squared | 0.50 | |
| Significance | 0 | |
| Slope | (61.81) | |
| Total Sum of Squares | 2.1M |
Brainstorm Dividend Paid And Capex Coverage Ratio History
About Brainstorm Cell Financial Statements
Investors use fundamental indicators, such as Brainstorm Cell's Dividend Paid And Capex Coverage Ratio, to determine how well the company is positioned to perform in the future. Although Brainstorm Cell's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Dividend Paid And Capex Coverage Ratio | -1.1 K | -1.1 K |
Currently Active Assets on Macroaxis
When determining whether Brainstorm Cell Ther offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Brainstorm Cell's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainstorm Cell Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brainstorm Cell Therapeutics Stock:Check out the analysis of Brainstorm Cell Correlation against competitors. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brainstorm Cell. If investors know Brainstorm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brainstorm Cell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.45) | Return On Assets (1.78) | Return On Equity (11.22) |
The market value of Brainstorm Cell Ther is measured differently than its book value, which is the value of Brainstorm that is recorded on the company's balance sheet. Investors also form their own opinion of Brainstorm Cell's value that differs from its market value or its book value, called intrinsic value, which is Brainstorm Cell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brainstorm Cell's market value can be influenced by many factors that don't directly affect Brainstorm Cell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brainstorm Cell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Brainstorm Cell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brainstorm Cell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.